Market Outlook

By 2035, the U.S. Short Dental Implants Market is expected to reach approximately USD 0.82 billion, expanding at a CAGR of 9.53% during the forecast period 2026–2035. The market is estimated at USD 0.33 billion in 2025, with historical analysis covering 2021–2024. The market expanded from approximately USD 0.23 billion in 2021 to USD 0.30 billion in 2024, supported by increasing implant treatment penetration, wider acceptance of graft-avoidance protocols, continued growth in the older adult population, and improvements in implant macrogeometry, surface technology, prosthetic connections, and digital treatment planning. Values in this report are expressed in USD billions.

For the purpose of this report, short dental implants primarily include root-form endosseous implants with an endosseous length of 8 mm or less, with implants of 6 mm or less considered extra-short. Market sizing represents manufacturer-level revenue associated with short implant fixtures and directly attributable implant system components. It excludes the full patient procedure charge, bone graft materials, CBCT equipment, dental laboratory revenue, and unrelated restorative products.

Short dental implants occupy a strategically important position between conventional implant therapy and more invasive bone-augmentation procedures. Their core value proposition is not simply reduced implant length. Their economic relevance comes from enabling implant-supported rehabilitation where residual vertical bone height may otherwise require sinus floor elevation, vertical ridge augmentation, nerve repositioning, or other additional surgery before placement of a conventional-length implant.

The addressable patient pool remains substantial. Severe tooth loss affects a meaningful proportion of older Americans, with approximately 26% of adults aged 65 years and above having eight or fewer teeth and about 15% having lost all natural teeth. Implant adoption has also risen materially: among U.S. adults aged 50 years and older, the prevalence of having at least one dental implant increased from approximately 1.3% in 1999–2004 to 8.4% in 2015–2020. These trends create a progressively larger population of patients reaching implant practices with posterior tooth loss, ridge resorption, reduced bone height, previous extractions, and anatomy that may favor shorter implants.

The U.S. market is expected to reach approximately USD 0.36 billion in 2026 and USD 0.52 billion by 2030, before progressing toward USD 0.82 billion in 2035. Growth is expected to outpace several mature conventional implant categories because short implants are gaining clinical credibility as a distinct treatment option rather than being viewed primarily as compromise implants for patients unable to receive standard treatment.

 

Introduction

According to the U.S. Short Dental Implants Market Report, demand is shaped by the convergence of population aging, tooth loss, growing patient acceptance of implant-based rehabilitation, increasing clinician familiarity with reduced-length designs, and pressure to simplify surgical pathways.

The United States represents an attractive commercial environment because it combines a large dental economy with sophisticated implant practices, oral surgeons, periodontists, prosthodontists, digitally enabled general dentists, dental support organizations, academic centers, and specialty referral networks. National dental expenditures reached approximately USD 189 billion in 2024, illustrating the scale of the dental care ecosystem within which implant therapy competes for patient spending.

There were more than 202,000 professionally active dentists in the U.S. in 2024, while the country contains more than 135,000 dental practice establishments. This fragmented but increasingly consolidated provider base creates multiple go-to-market pathways for implant manufacturers. Premium implant companies can penetrate specialist practices through clinical education and evidence, while value and mid-market manufacturers increasingly reach general practitioners and multi-location groups through simplified surgical kits, digital planning support, bundled restorative components, and continuing education.

Short implants are particularly relevant in posterior regions. After tooth loss, alveolar bone resorption and proximity to the maxillary sinus or inferior alveolar nerve can constrain available vertical bone. The conventional response has often involved augmentation followed by longer implants. Short implants create an alternative treatment pathway in selected patients by using available native bone more efficiently.

The commercial decision therefore extends beyond the fixture price. A clinician evaluating a 5–7 mm implant against a conventional implant combined with grafting may consider surgical appointments, treatment duration, membrane or graft costs, chair time, postoperative morbidity, patient acceptance, referral leakage, and the probability that a patient declines treatment when a complex surgical pathway is proposed.

This distinction is central to the U.S. market. Routine dental implant therapy is largely outside traditional Medicare dental coverage, and substantial patient financial responsibility remains common. Treatment plans that reduce procedural complexity can therefore have meaningful commercial value even when the individual implant carries premium pricing.

Over the forecast period, the strongest manufacturers will increasingly position short implants as part of an integrated atrophic-jaw workflow encompassing CBCT-based planning, surgical instrumentation, implant macrogeometry, restorative components, digital impressions, guided surgery, prosthetic design, maintenance protocols, and clinician education.

 

Key Market Drivers: What’s Fueling the U.S. Short Dental Implants Market Boom?

The first major driver is the scale of tooth loss and declining bone availability among older patients. Approximately one-quarter of Americans aged 65 years or older have eight or fewer natural teeth. Edentulism also rises sharply with age, reaching approximately 11% among adults aged 65–74 years and close to 20% among those aged 75 years and above in national surveillance data. Older implant candidates frequently present with long-standing edentulous sites, posterior ridge resorption, systemic comorbidities, or reduced willingness to undergo multiple surgeries.

A second driver is growing implant penetration. U.S. dental implant use has increased substantially over the last two decades. Implant-supported treatment has moved from a predominantly specialist procedure toward a broader restorative ecosystem involving general dentists, oral surgeons, periodontists, prosthodontists, DSOs, and implant-focused practices. As the overall implant market expands, clinicians encounter a larger number of anatomically difficult cases where shorter implants become commercially relevant.

The third driver is the economics of avoiding augmentation. In an atrophic posterior mandible, a conventional implant may require vertical augmentation where bone height above the inferior alveolar canal is inadequate. In the posterior maxilla, limited residual bone may lead to sinus augmentation. Randomized clinical evidence has shown that appropriately selected short implants can produce clinically competitive outcomes while reducing complications associated with augmentation in certain indications. This strengthens the economic argument for short-implant treatment.

For practices, fewer procedures can translate into faster case completion, lower surgical inventory consumption and reduced chair-time exposure. For patients, the proposition can mean fewer surgical interventions, less postoperative morbidity and a shorter route to definitive restoration. Those advantages are particularly valuable in a U.S. environment where out-of-pocket affordability significantly affects treatment acceptance.

A fourth driver is improving clinical evidence. Short implants historically faced skepticism because conventional implantology emphasized maximizing implant length to increase bone-to-implant contact. Newer designs have altered the mechanical equation through wider diameters, improved thread architecture, high-strength materials, surface modifications, platform switching and optimized implant-abutment connections.

Clinical outcomes remain indication-dependent, and short implants should not be treated as universally equivalent to longer fixtures. Nevertheless, long-term evidence has materially improved confidence. Recent evidence evaluating implants of 6 mm or less has reported implant-level ten-year survival approaching the mid-90% range in pooled analyses. Five-year clinical studies have also demonstrated survival near 98% in selected posterior mandibular applications, although other trials have shown lower survival for 6 mm single implants than 10 mm controls. This mixed evidence reinforces the importance of case selection rather than undermining the category.

The fifth driver is digital implant planning. CBCT imaging, intraoral scanning, virtual implant planning, guided surgery, digital restorative workflows and increasingly AI-assisted planning tools allow clinicians to assess available bone more precisely. Short implants benefit disproportionately from accurate planning because small differences in residual bone height, diameter selection, angulation and proximity to vital structures influence whether graftless placement is feasible.

A sixth driver is the growth of DSOs and multi-location dental organizations. Approximately 16% of U.S. dentists were affiliated with a DSO in 2024, up substantially from earlier years. Larger organizations can create standardized implant protocols across dozens or hundreds of practices. Short implant systems that simplify inventory, reduce external referrals and allow qualified clinicians to treat more complex anatomies can therefore generate enterprise-level commercial opportunities.

Finally, patient preference is becoming more influential. Implant candidates increasingly compare treatment time, surgery burden, financing and recovery rather than accepting augmentation automatically. A credible graftless or graft-reduced treatment plan can improve case acceptance, particularly among older adults and cost-sensitive self-pay patients.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in short dental implants is concentrated around achieving sufficient primary stability and durable load distribution from a reduced bone-contact length. This requires coordination between implant shape, diameter, thread geometry, material strength, surface characteristics, surgical preparation and prosthetic design.

Macrogeometry is one of the most important areas of competition. Manufacturers are using tapered bodies, deeper or more aggressive threads, variable thread pitch and apical cutting characteristics to increase initial fixation. These features are especially valuable in posterior maxillary sites where cancellous bone may be less dense.

Wide-diameter short implants represent another important design direction. Increasing diameter expands potential bone-to-implant contact and may improve the biomechanical foundation available for posterior molar loading. Bicon, ZimVie, BioHorizons, Straumann and other implant manufacturers offer systems that combine short lengths with diameter and thread options designed for reduced vertical bone.

Surface engineering is also critical. Blasted and acid-etched surfaces, hydrophilic surface technologies, microstructured collars and other surface modifications are intended to support predictable osseointegration despite reduced implant length. Straumann’s SLActive technology, BioHorizons’ Laser-Lok architecture and proprietary surface designs across other implant systems demonstrate how manufacturers differentiate beyond implant dimensions.

High-strength materials are widening the design envelope. Titanium remains the dominant material, while titanium alloys and titanium-zirconium compositions allow manufacturers to engineer smaller or shorter implants while targeting adequate fatigue resistance. Zirconia retains strategic interest among patients and clinicians seeking metal-free alternatives, although the short-implant segment remains overwhelmingly titanium-oriented.

Prosthetic engineering is becoming equally important. Short implants inherently generate higher crown-to-implant ratios in many posterior situations. Conical connections, platform switching, optimized screw mechanics, splinted restorations where appropriate and carefully designed emergence profiles can therefore influence long-term performance.

Digital workflows are moving short implants from a standalone product toward a procedural ecosystem. Virtual planning allows the clinician to model residual bone, implant diameter, prosthetic trajectory and anatomical safety margins before surgery. Guided workflows may improve predictability when only limited vertical bone is available. Digital restorative design also allows the prosthesis to be planned around load distribution rather than treating the restorative phase as separate from implant placement.

The next competitive frontier will involve data-assisted case selection. Manufacturers that connect imaging, implant planning, surgical protocols and outcomes data can help clinicians identify when an extra-short implant is appropriate, when a 7–8 mm implant provides adequate anatomy, and when augmentation remains the safer treatment.

 

Segmentation Insights

The U.S. Short Dental Implants Market is segmented on the basis of implant length, clinical indication, prosthetic configuration, material and surface technology, and end user.

 

By Implant Length

4 mm and Below Extra-Short Implants

The 4 mm and below category represents the most technically differentiated part of the market. These implants address severely reduced vertical bone where conventional fixtures would often require augmentation. Their addressable use is concentrated in carefully selected posterior and atrophic cases rather than routine implant dentistry.

Commercial interest is increasing as stronger materials, larger diameters and improved macrogeometry strengthen the graftless proposition. Straumann’s 4 mm tissue-level platforms and Bicon’s longstanding extra-short portfolio illustrate this strategy. This segment is expected to achieve one of the highest growth rates through 2035 but will remain dependent on clinician training and disciplined prosthetic planning.

Above 4 mm to 6 mm Implants

The above 4–6 mm category is expected to represent a major growth pool because it balances anatomical conservation with a broader clinical evidence base. Six-millimeter implants have been evaluated across posterior maxillary and mandibular settings, including comparisons with longer implants and augmentation.

These products are increasingly considered when residual bone makes conventional placement difficult but adequate width and primary stability can still be achieved. BioHorizons, Straumann, ZimVie, Bicon and several international implant manufacturers participate in this range.

Above 6 mm to 8 mm Implants

The above 6–8 mm segment represents the largest commercial portion of the short-implant market in 2025. These implants require less radical modification of conventional implant protocols and can be integrated into a wider range of posterior treatment plans.

Seven- and eight-millimeter implants are attractive to clinicians seeking to avoid anatomical structures without moving directly into an extra-short protocol. Their clinical learning curve is generally more compatible with mainstream implant practices, making this category particularly important for general dentists and DSOs expanding implant services.

 

By Clinical Indication

Atrophic Posterior Mandible

The atrophic posterior mandible is one of the most important short-implant indications. Loss of vertical ridge height above the inferior alveolar canal can restrict the placement of conventional-length implants. Alternative approaches such as vertical bone augmentation increase procedural complexity.

Short implants can allow clinicians to use available native bone while maintaining a safety margin from the nerve. This indication has a strong clinical-economic value proposition because avoiding augmentation can materially reduce the treatment pathway.

Atrophic Posterior Maxilla

The posterior maxilla represents another high-value segment because progressive sinus pneumatization and ridge resorption can reduce available bone following molar loss. Traditional implant rehabilitation may involve crestal or lateral sinus elevation depending on residual anatomy.

Six-millimeter and other short implants can be alternatives in selected patients when sufficient residual bone exists for primary stability. Demand is supported by the high prevalence of posterior tooth loss and the desire to reduce sinus-related surgical intervention.

Single-Tooth Posterior Replacement

Single molar and premolar replacement is an important but clinically demanding segment. Unlike splinted restorations, a single crown concentrates functional loading onto an individual implant. Diameter, crown height, occlusion and parafunctional risk become particularly important.

Short implants are gaining acceptance in this application but are likely to remain more selectively used than in splinted posterior restorations because evidence has demonstrated variability in survival depending on protocol and implant design.

Short-Span Bridges and Splinted Restorations

Splinted short implants are strategically attractive in posterior partially edentulous patients because load can be distributed across multiple fixtures. Implant manufacturers frequently emphasize prosthetic planning and adequate implant diameter in this population.

This segment is expected to maintain strong adoption among periodontists, oral surgeons and implant-focused restorative practices managing patients with multiple missing posterior teeth.

Full-Arch and Overdenture Support

Short implants represent a smaller but growing component of full-arch and overdenture treatment. They may be incorporated into selected severely resorbed anatomies, sometimes alongside longer anterior implants. Rather than replacing established tilted-implant or remote-anchorage strategies universally, short implants expand the clinician’s toolkit for avoiding grafting.

 

By Prosthetic Configuration

Single Crowns

Single-crown restorations represent a clinically visible segment because molar replacement creates high occlusal demand and often a relatively high crown-to-implant ratio. Premium implant manufacturers compete through strong implant-abutment interfaces, wider posterior diameters and digitally designed screw-retained restorative workflows.

Splinted Crowns and Fixed Partial Dentures

Splinted restorations represent a particularly important configuration for extra-short implants. By distributing forces across multiple implants, splinting can improve the biomechanical environment in appropriately planned posterior cases. This segment is expected to remain important in reduced-bone-height patients with several adjacent missing teeth.

Implant-Supported Overdentures

Short implants can support removable implant prostheses where anatomical limitations restrict conventional implant length. Demand is associated with aging and severe tooth loss. Patient affordability remains important, and manufacturers that provide simplified restorative components and predictable maintenance may gain share.

Fixed Full-Arch Prostheses

Use in fixed full-arch rehabilitation remains selective but commercially relevant. Short implants may function as supplementary posterior support in graftless treatment planning. Growth will depend on digital full-arch workflows, restorative engineering and stronger evidence defining when short implants should complement versus replace other anchorage strategies.

 

By Material and Surface Technology

Commercially Pure Titanium and Titanium Alloy

Titanium-based implants overwhelmingly dominate U.S. short-implant demand. Titanium’s established biocompatibility, mechanical properties and extensive clinical history make it the preferred platform for reduced-length implants.

The segment includes commercially pure titanium and higher-strength titanium alloys. Manufacturers differentiate through grade selection, thread design, surface processing and connection mechanics rather than material alone.

Titanium-Zirconium and High-Strength Alloy Platforms

High-strength alloy systems are strategically important because reduced implant dimensions place increased emphasis on mechanical performance. Titanium-zirconium systems allow manufacturers to support compact implant designs while maintaining strength requirements.

This category is particularly attractive in premium implant portfolios and anatomically constrained cases where the combination of shorter length and optimized diameter is required.

Zirconia Short Implants

Zirconia remains a niche segment. Patient interest in metal-free dentistry and soft-tissue esthetics supports long-term opportunity, but availability of short zirconia configurations, restorative flexibility and clinical evidence remain more limited than titanium.

Growth is expected from a small base rather than through near-term displacement of titanium.

Advanced Surface-Treated Implants

Surface-treated short implants are expected to capture the majority of premium market value. Hydrophilic surfaces, sandblasted and acid-etched surfaces, microstructured collars and manufacturer-specific surface technologies are used to optimize early bone response and peri-implant tissue management.

Surface differentiation is especially important in short implants because clinicians have less implant length available for osseointegration. Products supported by convincing clinical evidence can therefore sustain premium pricing.

 

By End User

Oral Surgery and Periodontal Practices

Oral surgeons and periodontists represent a critical end-user group because they manage advanced bone deficiency, failed dentition and complex posterior anatomy. These specialists are also influential clinical educators and referral partners.

Short-implant manufacturers depend heavily on this segment for evidence-based adoption. Specialist endorsement can subsequently support penetration into advanced general practices and DSOs.

General Dental and Implant-Focused Practices

General dentists represent the largest long-term expansion opportunity. More clinicians are incorporating implant placement rather than referring every surgical case. Digital planning, simplified drilling protocols and structured training make short implants more accessible to experienced general practitioners.

Manufacturers that can provide a coherent surgical and restorative ecosystem are better positioned than companies selling the fixture alone.

Dental Support Organizations and Group Practices

DSOs are becoming strategically important purchasers. Approximately 16% of U.S. dentists are now affiliated with DSOs, creating greater potential for standardized vendor contracting.

A DSO can evaluate short implants through procedure conversion, internal referral retention, complication rates, clinical training requirements, inventory complexity and per-case profitability. Manufacturers that demonstrate reproducibility across clinicians can secure broader contracts.

Prosthodontic and Advanced Restorative Centers

Prosthodontists influence the restorative design of short implant cases and are particularly important for complex crown-to-implant relationships, splinted prostheses and full-arch rehabilitation. This end-user segment values connection stability, restorative component depth, digital libraries and laboratory compatibility.

Academic, Hospital and Veteran-Focused Dental Centers

Academic dental centers and hospital-based programs provide a smaller commercial share but significant evidence-generation value. They contribute to clinical studies, postgraduate implant training and treatment of medically complex patients. Veteran-focused and public dental environments also contain substantial tooth-loss burden, although reimbursement and procurement structures can constrain premium implant adoption.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Short Dental Implants Market is geographically segmented into the South, West, Northeast and Midwest. Regional estimates are modeled using population, older-adult concentration, dental spending capacity, dentist supply, implant infrastructure, urban specialty density and likely prevalence of complex restorative treatment.

The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast remains an influential premium and specialist-driven region, whereas the Midwest provides a stable base of implant dentistry with significant opportunity in large metropolitan and referral markets.

South

The South accounted for an estimated USD 0.12 billion in 2025 and is projected to approach USD 0.31 billion by 2035, representing close to a 10% regional CAGR.

Texas and Florida form the commercial center of the Southern market. Texas combines a very large population with implant-heavy metropolitan areas including Houston, Dallas-Fort Worth, Austin and San Antonio. Large group practices, oral surgery networks and rapidly expanding suburban populations create favorable conditions for advanced implant therapy. Florida is particularly attractive because of its large older population, strong retirement migration and high concentration of restorative and implant-focused dentistry. Short implants are relevant for older patients presenting with long-standing posterior tooth loss and alveolar resorption.

North Carolina and Georgia are strong growth markets. Charlotte, Raleigh-Durham, Atlanta and surrounding suburban corridors support sophisticated dental and specialty networks. Tennessee has growing implant activity around Nashville, Memphis, Knoxville and Chattanooga, while Virginia benefits from affluent Northern Virginia markets, Richmond and major coastal population centers.

Maryland and Delaware contain relatively high-income dental markets with access to specialty providers, while South Carolina is expanding with demographic growth in Charleston, Greenville and coastal retirement communities. Kentucky and West Virginia have meaningful tooth-loss burden, making the clinical need substantial even where affordability constrains conversion to implant therapy.

Alabama, Mississippi, Arkansas and Louisiana present mixed market dynamics. Tooth-loss need is considerable, but provider access and household affordability can limit premium implant penetration outside larger cities. Short implants can nevertheless offer a compelling proposition where avoiding a second grafting procedure materially reduces overall treatment burden.

Oklahoma combines metropolitan implant demand in Oklahoma City and Tulsa with broader rural access constraints. The state represents a practical market for systems that can be used by experienced general dentists without requiring complex tertiary referral infrastructure.

Overall, Southern growth will be driven by population migration, aging, expanding DSOs, stronger implant penetration in general dentistry and the commercial benefit of reducing complex grafting procedures.

West

The West represented approximately USD 0.08 billion in 2025 and is projected to reach roughly USD 0.22 billion by 2035, producing an estimated CAGR of approximately 10.7% and making it the fastest-growing region.

California is the region’s largest state-level opportunity and one of the largest short-implant markets nationally. Los Angeles, San Diego, the Bay Area, Sacramento and other major metros contain high concentrations of specialists, affluent restorative patients, dental laboratories, digitally enabled practices and implant education networks. California is also highly receptive to digital workflows and premium implant platforms.

Arizona and Nevada are major growth markets because of population expansion and older-adult migration. Phoenix, Scottsdale, Tucson and Las Vegas have strong implant and full-arch treatment ecosystems. Patients relocating into these states often present with significant prior restorative dentistry and posterior tooth loss, supporting advanced implant demand.

Washington and Oregon represent mature, digitally sophisticated dental markets. Seattle and Portland support high adoption of CBCT planning, intraoral scanning and premium restorative workflows. Short implants are likely to gain adoption where clinicians can integrate anatomical planning directly into digital surgical and prosthetic pathways.

Colorado and Utah have strong demographic and economic fundamentals. Denver, Colorado Springs, Salt Lake City and rapidly expanding suburban markets support implant practice growth. Their younger population profiles relative to Florida reduce immediate edentulism burden but rising lifetime implant penetration supports long-term demand.

New Mexico has clinically meaningful tooth-loss need but lower specialist density in many areas. Idaho and Montana are smaller markets experiencing population inflows, while Wyoming remains primarily referral-oriented because of low population density.

Alaska and Hawaii are small in revenue terms but distinctive. Geographic access and travel requirements can make treatment simplification valuable. Avoiding an additional augmentation procedure may have disproportionate appeal when patients travel substantial distances to implant centers.

The West will gain share through rapid digital adoption, strong population migration, premium dentistry, implant-focused practices and receptivity to newer graftless protocols.

Northeast

The Northeast accounted for an estimated USD 0.07 billion in 2025 and could reach approximately USD 0.17 billion by 2035, representing a CAGR of approximately 9.3%.

New York is the largest Northeast market. New York City contains a dense ecosystem of periodontists, prosthodontists, oral surgeons, general implantologists, academic centers and premium restorative practices. Short implants can gain adoption rapidly when backed by clinical evidence because specialists routinely manage anatomically complex referral cases.

New Jersey is another high-value market with strong suburban dental spending and close integration with the New York and Philadelphia healthcare corridors. Pennsylvania contributes large implant volumes through Philadelphia, Pittsburgh and regional health and dental networks.

Massachusetts is strategically influential because of Boston’s concentration of dental schools, academic institutions and specialty clinicians. The state may represent a smaller unit market than New York but has disproportionate influence on clinical education and technology evaluation.

Connecticut and Rhode Island support premium restorative dentistry within compact geographies and relatively dense provider markets. New Hampshire and Maine have older demographic profiles that create clinical demand for posterior rehabilitation, although rural provider distribution can restrict access.

Vermont remains a small market by absolute value but represents the same fundamental need: aging dentition combined with fewer specialist centers outside major population clusters.

The Northeast will remain particularly important for evidence-based premium manufacturers. Clinicians in this region are likely to demand high-quality long-term data, well-designed restorative systems and clear indications rather than adopting short implants purely as a lower-cost alternative.

Midwest

The Midwest represented approximately USD 0.06 billion in 2025 and is forecast to reach around USD 0.12 billion by 2035. Growth is expected to be steadier than in the South or West.

Illinois is the region’s leading market, with Chicago supporting major specialist practices, academic dental programs and sophisticated restorative treatment. Ohio also contains substantial implant demand across Cleveland, Columbus and Cincinnati, while Michigan’s Detroit metropolitan area provides a large established dental care base.

Minnesota has strategic relevance because of its medical technology culture, high healthcare sophistication and strong Twin Cities provider infrastructure. Wisconsin supports steady implant use around Milwaukee and Madison.

Indiana and Missouri are attractive mid-sized markets. Indianapolis, St. Louis and Kansas City contain well-developed oral surgery and implant networks. Iowa, Kansas and Nebraska provide smaller but stable demand, with cases often concentrating in metropolitan and university-associated referral centers.

North Dakota and South Dakota represent limited absolute market size but substantial geographic dispersion. The ability to complete implant treatment with fewer surgical stages can be valuable for patients traveling from rural communities to regional specialists.

The Midwest is likely to favor implant manufacturers offering reliable clinical support, competitive contracting, efficient inventory systems and continuing education. Growth will be less dependent on luxury dentistry and more closely tied to clinical need, referral networks and practical procedure economics.

 

Key Market Players

The U.S. Short Dental Implants Competitive Landscape is moderately fragmented, but premium implant demand is concentrated among manufacturers with established clinician relationships, broad prosthetic ecosystems, clinical evidence and digital workflow capabilities.

Short implants are not an isolated category for most multinational competitors. Leading manufacturers compete by embedding reduced-length implants within larger platforms containing conventional fixtures, abutments, guided surgery, regenerative products, restorative components and digital treatment-planning solutions.

Some of the key companies and implant platforms relevant to the U.S. Short Dental Implants industry include Institut Straumann AG, Straumann USA, Neodent, Anthogyr, Nobel Biocare, Implant Direct, Dentsply Sirona, ZimVie, BioHorizons, CAMLOG, Bicon Dental Implants, Hiossen Implant, Osstem Implant, Dentium USA, MegaGen America, Keystone Dental, Southern Implants, Neoss, MIS Implants Technologies, ACE Surgical Supply, Blue Sky Bio, Noris Medical, Cortex Dental Implants and ADIN Dental Implant Systems.

Straumann holds a strategically strong position because of its premium brand, surface technologies, high-strength material platform, digital workflow ecosystem and dedicated short and extra-short implant configurations. Its short-implant portfolio provides a direct clinical proposition for patients with limited bone availability.

Bicon remains unusually important to this category because short implants are fundamental to its historical product philosophy rather than a small extension of a conventional implant portfolio. Its 5 mm and 6 mm configurations and long-standing clinical positioning provide brand recognition among clinicians specifically interested in extra-short implants.

BioHorizons competes through Tapered Short implants available in reduced lengths, combined with its Laser-Lok surface architecture. ZimVie’s T3 Short platform provides another purpose-built approach for vertical height deficiencies and is supported by dedicated instrumentation.

Nobel Biocare competes through a broad implant and digital ecosystem, with shorter posterior options embedded within platforms designed for complex implant treatment. Dentsply Sirona, Implant Direct, Hiossen/Osstem, Dentium, MegaGen, Southern Implants and other manufacturers expand competition across premium, value and specialist segments.

Over the forecast period, market share will increasingly be determined by five capabilities: clinical evidence supporting reduced-length indications, implant and connection strength, restorative ecosystem depth, digital planning integration, and the manufacturer’s ability to train clinicians in case selection.

Pricing alone will not determine leadership. A manufacturer that reduces graft requirements, lowers surgical complexity and helps a practice retain cases internally can justify a premium fixture even in a price-sensitive environment.

 

Recent Developments

Recent market developments indicate that short implants are becoming more deeply integrated into mainstream implant portfolios.

In 2026, Straumann expanded attention around its TLX 4 mm extra-short implant, positioning the platform for patients with severely reduced bone availability and graftless treatment strategies. The development is strategically important because it places a 4 mm solution within a major premium implant ecosystem rather than treating extra-short implants as a specialist niche.

BioHorizons continues to commercialize its Tapered Short implant platform in 6 mm and 7.5 mm lengths, targeting cases with limited vertical bone while emphasizing implant stability and its Laser-Lok surface architecture.

ZimVie maintains a dedicated T3 Short Dental Implant platform for vertical height deficiencies and in 2026 introduced a new modular TSX surgical kit for its broader implant portfolio. Although the TSX kit is not exclusively a short-implant development, the move reflects a broader competitive shift toward streamlined instrumentation and platform integration.

Nobel Biocare introduced its new S series implant system in 2026, emphasizing harmonization around a common prosthetic connection and simplified workflow. This illustrates a key direction for the overall implant industry: reducing component complexity while allowing clinicians to select implant geometries according to anatomy.

Digital treatment planning continues to advance simultaneously. Implant companies increasingly link CBCT imaging, prosthetically driven planning, guided surgery, intraoral scanning and CAD/CAM restoration. Short implants are a natural beneficiary because accurate three-dimensional assessment of residual bone determines whether a patient can be treated without augmentation.

Clinical evidence has also continued to mature. A 2026 systematic review evaluating ten-year outcomes for implants of 6 mm or less reported pooled implant-level survival of approximately 93.7%. The finding does not eliminate the need for careful case selection, but long-term evidence of this type strengthens clinician confidence in a category that historically faced concern about reduced surface area and biomechanical loading.

Competitive consolidation is another relevant development. Ownership changes, portfolio acquisitions and integration of digital and implant businesses are increasing pressure on smaller manufacturers to provide complete workflows rather than fixtures alone. Procurement decisions in larger dental groups increasingly consider surgical kits, restorative libraries, training, digital interoperability, supply consistency and volume contracting simultaneously.

 

Conclusion

The U.S. Short Dental Implants Market Size & Share is positioned to expand from approximately USD 0.33 billion in 2025 to USD 0.82 billion by 2035, representing a CAGR of 9.53% during 2026–2035. Historical market value increased from approximately USD 0.23 billion in 2021 to USD 0.30 billion in 2024 as implant penetration recovered and clinicians expanded the use of graft-reducing treatment concepts.

The market is moving from a compromise-driven clinical category toward a strategically distinct segment of implant dentistry. Short implants increasingly compete not against conventional implants alone but against an entire alternative treatment pathway involving graft materials, augmentation surgery, additional appointments, postoperative recovery and delayed restoration.

The strongest opportunity lies in posterior atrophic anatomy. Reduced vertical bone in the posterior mandible and maxilla creates a clear clinical use case, especially among older adults who have experienced years of tooth loss and ridge resorption.

The economic argument will become increasingly influential. Short implants can allow qualified clinicians to treat selected patients through fewer surgical stages, potentially improve case acceptance and reduce referral leakage. These benefits align with the priorities of implant-focused general practices and DSOs as well as specialist centers.

However, growth should not be interpreted as evidence that short implants will replace conventional-length implants or augmentation universally. Outcomes remain dependent on bone quality, implant diameter, loading, prosthetic design, systemic risk, smoking, periodontal status, clinician skill and maintenance. Evidence for some extra-short applications is strong, while individual trials continue to demonstrate differences in survival under specific protocols.

The competitive advantage will therefore move toward companies that help clinicians make the correct treatment decision rather than simply offering the shortest fixture. Manufacturers combining evidence-based implant design, high-strength materials, advanced surfaces, stable restorative connections, guided planning and structured education will be positioned to capture premium growth.

Regionally, the South is expected to remain the largest U.S. market, supported by Texas, Florida and fast-growing Southeastern states. The West is projected to grow fastest, led by California, Arizona, Nevada, Washington, Colorado and Utah. The Northeast will remain an evidence-intensive premium market, while the Midwest will provide durable demand across large metropolitan and regional referral networks.

For manufacturers, investors, DSOs, distributors and dental technology companies evaluating the U.S. Short Dental Implants Market, the central commercial question is no longer whether shorter implants can function clinically. The more important questions are which anatomies provide the strongest risk-adjusted use case, how much surgical complexity can be removed from the patient pathway, which implant designs can sustain posterior loading over the long term, and which manufacturers can convert clinical evidence into scalable practice economics.

Those dynamics are expected to define the next decade of U.S. short dental implant adoption.

 

TABLE OF CONTENT

1. U.S. Short Dental Implants Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Bottom-Up & Top-Down Analytical Framework
1.3.6. Forecasting Models & Scenario Validation
1.3.7. Data Triangulation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Short Dental Implant Manufacturers
1.6.2. Implant Components and Biomaterial Suppliers
1.6.3. Oral Surgeons and Periodontists
1.6.4. Prosthodontists and Implant-Focused General Dentists
1.6.5. Dental Support Organizations and Group Practices
1.6.6. Dental Laboratories and Digital Dentistry Partners
1.6.7. Distributors and Specialty Dental Suppliers
1.6.8. Dental Insurers, Patient Financing Providers, Regulators, and Clinical Decision-Makers
What this section provides: This section defines the U.S. short dental implants market boundary, study scope, sizing methodology, assumptions, product inclusion criteria, and stakeholder ecosystem so clients understand how the market is measured and validated.

2. U.S. Short Dental Implants Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Short Dental Implant Adoption versus Conventional Implant & Bone Augmentation Pathways
2.8. High-Growth Opportunity Areas
2.8.1. Extra-Short Implants for Severe Vertical Bone Deficiency
2.8.2. Graft-Avoidance in the Atrophic Posterior Mandible
2.8.3. Short Implants as Alternatives to Sinus Augmentation
2.8.4. Digital and Guided Short Implant Placement
2.8.5. DSO and General Dentist Implant Program Expansion
What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical development, competitive positioning, high-growth clinical indications, and the most commercially attractive short dental implant opportunities through 2035.

3. U.S. Short Dental Implants Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Tooth Loss and Edentulism Among U.S. Adults
3.1.2. Growing Dental Implant Penetration
3.1.3. Increasing Geriatric Population and Posterior Ridge Resorption
3.1.4. Growing Preference for Graft-Avoidance Treatment Protocols
3.1.5. Rising Adoption of Short Implants in Atrophic Posterior Jaws
3.1.6. Expansion of Implant Dentistry Among General Practitioners
3.1.7. Growth of Dental Support Organizations
3.1.8. Increasing Adoption of CBCT and Digital Implant Planning
3.2. Restraints and Their Impact Analysis
3.2.1. Higher Crown-to-Implant Ratio Concerns
3.2.2. Variable Long-Term Evidence Across Implant Lengths and Indications
3.2.3. Limited Dental Insurance Coverage for Implant Therapy
3.2.4. High Patient Out-of-Pocket Cost
3.2.5. Clinician Preference for Conventional-Length Implants
3.2.6. Requirement for Advanced Case Selection and Prosthetic Planning
3.3. Opportunities and Their Impact Analysis
3.3.1. 4–6 mm Extra-Short Implant Adoption
3.3.2. Graftless Posterior Mandibular Rehabilitation
3.3.3. Reduced Need for Sinus Floor Augmentation
3.3.4. Digital Guided Implant Surgery
3.3.5. Expansion of Implant Treatment Within DSOs
3.3.6. Older and Medically Complex Patient Populations
3.3.7. Integrated Surgical-Restorative Implant Platforms
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Evidence & Long-Term Implant Survival Analysis
3.7. Clinical Workflow Economics Analysis
3.7.1. Short Implant versus Bone Augmentation Economics
3.7.2. Short Implant versus Sinus Lift Treatment Economics
3.7.3. Procedure Time and Chair-Time Economics
3.7.4. Patient Treatment Acceptance Economics
3.7.5. Referral Retention and Practice Revenue Impact
3.8. Dental Practice and DSO Procurement Behavior Analysis
What this section provides: This section analyzes the clinical, demographic, economic, reimbursement, adoption, and operational forces affecting short implant demand and helps clients assess market upside, treatment conversion opportunities, and execution risks.

4. U.S. Short Dental Implants Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Dental Practices and DSOs
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Short Dental Implant Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Implant Manufacturing and Raw Material Analysis
4.6. Impact of Digital Dentistry and Guided Implantology
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. Dental Insurance, Patient Financing & Reimbursement Landscape
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Oral Health Initiatives and Public Dental Programs
4.12. Impact of Escalating Geopolitical and Supply Chain Tensions
4.13. DSO and Group Practice Vendor Selection Framework
4.14. Clinical Evidence Requirements for New Product Adoption
What this section provides: This section gives clients a complete view of the regulatory, pricing, competitive, supply-chain, reimbursement, technological, and dental procurement environment affecting U.S. short dental implant commercialization.

5. U.S. Short Dental Implants Market – By Implant Length

5.1. Overview
5.1.1. Segment Share Analysis, By Implant Length, 2025 & 2035 (%)
5.1.2. 4 mm and Below Extra-Short Implants
5.1.3. Above 4 mm to 6 mm Implants
5.1.4. Above 6 mm to 8 mm Implants
5.1.5. Implant Length Adoption by Posterior Maxillary versus Mandibular Anatomy
5.1.6. Implant Length Clinical Evidence and Survival Comparison
What this section provides: This section identifies which short and extra-short implant lengths generate the largest revenue contribution, strongest adoption momentum, and greatest clinical opportunity through 2035.

6. U.S. Short Dental Implants Market – By Clinical Indication

6.1. Overview
6.1.1. Segment Share Analysis, By Clinical Indication, 2025 & 2035 (%)
6.1.2. Atrophic Posterior Mandible
6.1.3. Atrophic Posterior Maxilla
6.1.4. Single-Tooth Posterior Replacement
6.1.5. Short-Span Bridges and Splinted Restorations
6.1.6. Full-Arch Rehabilitation
6.1.7. Implant-Supported Overdentures
6.1.8. Graft-Avoidance Applications
6.1.9. Sinus-Augmentation Avoidance Applications
What this section provides: This section evaluates clinical demand by anatomical and restorative indication and identifies applications where short implants can provide the strongest clinical and economic alternative to conventional-length implants and augmentation.

7. U.S. Short Dental Implants Market – By Prosthetic Configuration

7.1. Overview
7.1.1. Segment Share Analysis, By Prosthetic Configuration, 2025 & 2035 (%)
7.1.2. Single Crowns
7.1.3. Splinted Crowns
7.1.4. Fixed Partial Dentures
7.1.5. Implant-Supported Overdentures
7.1.6. Fixed Full-Arch Prostheses
7.1.7. Screw-Retained Restorations
7.1.8. Cement-Retained Restorations
What this section provides: This section shows how restorative design influences short implant demand, biomechanical risk, treatment selection, and revenue opportunity across single-unit, multiple-unit, removable, and full-arch treatment.

8. U.S. Short Dental Implants Market – By Material & Surface Technology

8.1. Overview
8.1.1. Segment Share Analysis, By Material & Surface Technology, 2025 & 2035 (%)
8.1.2. Commercially Pure Titanium Implants
8.1.3. Titanium Alloy Implants
8.1.4. Titanium-Zirconium and High-Strength Alloy Implants
8.1.5. Zirconia Short Implants
8.1.6. Sandblasted and Acid-Etched Surface Implants
8.1.7. Hydrophilic Surface Implants
8.1.8. Microstructured and Laser-Modified Surface Implants
8.1.9. Other Proprietary Advanced Surface Technologies
What this section provides: This section evaluates the materials and surface technologies affecting osseointegration, fatigue strength, primary stability, premium pricing, and competitive differentiation within the short dental implant market.

9. U.S. Short Dental Implants Market – By End User

9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
9.1.2. Oral Surgery Practices
9.1.3. Periodontal Practices
9.1.4. Prosthodontic and Advanced Restorative Practices
9.1.5. General Dental and Implant-Focused Practices
9.1.6. Dental Support Organizations and Group Practices
9.1.7. Academic Dental Centers
9.1.8. Hospital-Based and Veteran-Focused Dental Centers
What this section provides: This section identifies the provider settings expected to drive short implant placement, product purchasing, protocol standardization, clinician training, and future adoption across the United States.

10. U.S. Short Dental Implants Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Dental Implant Procedure and Provider Infrastructure Analysis
10.1.4. Regional Tooth Loss, Older Adult Population, and Atrophic Jaw Demand Analysis
10.1.5. Regional DSO Penetration and Implant Practice Concentration
10.1.6. Regional Dental Spending, Patient Affordability, and Financing Dynamics

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Short Dental Implant Key Manufacturers and Distribution Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Short Dental Implant Key Manufacturers and Distribution Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Short Dental Implant Key Manufacturers and Distribution Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Short Dental Implant Key Manufacturers and Distribution Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Implant Length, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Clinical Indication, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Prosthetic Configuration, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Material & Surface Technology, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed four-region and 50-state analysis, helping clients identify priority U.S. geographies, dental implant treatment hubs, older-adult demand pockets, specialist and DSO concentration, graft-avoidance opportunities, and state-level commercial potential.

11. U.S. Short Dental Implants Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Short-Implant Specialists
11.2.4. Innovators
11.2.5. Emerging and Value-Segment Players
11.3. Company Profiles
11.3.1. Straumann Group
11.3.2. Nobel Biocare
11.3.3. Dentsply Sirona
11.3.4. ZimVie Inc.
11.3.5. BioHorizons
11.3.6. Bicon Dental Implants
11.3.7. Implant Direct
11.3.8. Neodent
11.3.9. Anthogyr
11.3.10. CAMLOG
11.3.11. Hiossen Implant
11.3.12. Osstem Implant
11.3.13. Dentium
11.3.14. MegaGen Implant
11.3.15. Keystone Dental
11.3.16. Southern Implants
11.3.17. Neoss
11.3.18. MIS Implants Technologies
11.3.19. ACE Surgical Supply
11.3.20. Blue Sky Bio
11.3.21. Noris Medical
11.3.22. Cortex Dental Implants Industries
11.3.23. ADIN Dental Implant Systems
11.3.24. Thommen Medical
11.3.25. Ditron Dental USA
11.4. Competitive Benchmarking by Shortest Implant Length Offered
11.5. Competitive Benchmarking by Implant Surface Technology
11.6. Competitive Benchmarking by Digital Workflow Capabilities
11.7. Competitive Benchmarking by U.S. Distribution and Clinical Education Infrastructure
Note: Each company profile will include company overview, relevant short dental implant portfolio, implant length range, material and surface technologies, U.S. market strategy, digital workflow capabilities, distribution presence, clinical evidence, regulatory positioning, partnerships, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, short-implant portfolio positioning, technology differentiation, U.S. commercialization strategies, and strategic intelligence on leading implant manufacturers.

12. U.S. Short Dental Implants Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Extra-Short 4 mm and Below Implant Platforms
12.2.2. High-Strength Titanium and Titanium-Zirconium Materials
12.2.3. Hydrophilic and Advanced Osseointegrative Surfaces
12.2.4. AI-Assisted Implant Treatment Planning
12.2.5. CBCT-Based Guided Short Implant Surgery
12.2.6. Fully Digital Surgical-Restorative Workflows
12.2.7. Robotic and Navigation-Assisted Implant Placement
12.3. Emerging Clinical and Business Trends
12.4. Shift from Bone Augmentation toward Graft-Avoidance Protocols
12.5. General Dentist versus Specialist Adoption Outlook
12.6. DSO Implant Standardization Outlook
12.7. Business Opportunities for Startups and Existing Players
12.8. Investment Prioritization Matrix
12.9. Product White-Space Analysis
What this section provides: This section prepares clients for future clinical, technological, competitive, and business-model changes influencing short dental implant adoption and identifies the most important investment and product-development opportunities through 2035.

13. U.S. Short Dental Implants Market: Strategic Recommendations

13.1. Recommendations for Dental Implant Manufacturers
13.2. Recommendations for Oral Surgery and Periodontal Practices
13.3. Recommendations for General Dental and Implant-Focused Practices
13.4. Recommendations for Dental Support Organizations
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Dental Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. Clinical Education and Key Opinion Leader Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Premium versus Value-Segment Positioning
13.12. DSO Enterprise Contracting Strategy
13.13. Digital Dentistry Partnership Strategy
What this section provides: This section converts market intelligence into actionable strategy for portfolio development, clinical positioning, clinician education, DSO penetration, channel expansion, investment decisions, and competitive differentiation in the U.S. market.

14. U.S. Short Dental Implants Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Definition and Product Classification Limitation
14.4. Forecasting Limitation
14.5. Clinical Data Interpretation Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s market-definition boundaries, research limitations, clinical-data interpretation constraints, data-use terms, legal considerations, and forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Short Dental Implants Market: Market Definition and Scope
TABLE 3: U.S. Short Dental Implants Market: Research Methodology Framework
TABLE 4: U.S. Short Dental Implants Market: Key Assumptions
TABLE 5: U.S. Short Dental Implants Market: Market Ecosystem Overview
TABLE 6: U.S. Short Dental Implants Market: Stakeholder Analysis
TABLE 7: U.S. Short Dental Implants Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Short Dental Implants Market: Analyst Viewpoint Summary
TABLE 9: U.S. Short Dental Implants Market: Market Attractiveness Index
TABLE 10: U.S. Short Dental Implants Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Short Dental Implants Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Short Dental Implants Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Short Dental Implants Market: High-Growth Opportunity Areas
TABLE 14: U.S. Short Dental Implants Market: Drivers; Impact Analysis
TABLE 15: U.S. Short Dental Implants Market: Restraints; Impact Analysis
TABLE 16: U.S. Short Dental Implants Market: Opportunities; Impact Analysis
TABLE 17: U.S. Short Dental Implants Market: Challenges; Impact Analysis
TABLE 18: U.S. Short Dental Implants Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Short Dental Implants Market: Clinical Evidence & Long-Term Survival Analysis
TABLE 20: U.S. Short Dental Implants Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Short Dental Implants Market: Short Implant versus Bone Augmentation Economics
TABLE 22: U.S. Short Dental Implants Market: Dental Practice & DSO Procurement Behavior Matrix
TABLE 23: U.S. Short Dental Implants Market: PESTEL Analysis
TABLE 24: U.S. Short Dental Implants Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Short Dental Implants Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Short Dental Implants Market: Value Chain Analysis
TABLE 27: U.S. Short Dental Implants Market: Supply Chain Analysis
TABLE 28: U.S. Short Dental Implants Market: Implant Manufacturing & Raw Material Analysis
TABLE 29: U.S. Short Dental Implants Market: Digital Dentistry & Guided Implantology Impact
TABLE 30: U.S. Short Dental Implants Market: Application & Innovation Landscape
TABLE 31: U.S. Short Dental Implants Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Short Dental Implants Market: Dental Insurance, Patient Financing & Reimbursement Landscape
TABLE 33: U.S. Short Dental Implants Market: Import/Export Restrictions & Tariff Impact
TABLE 34: U.S. Short Dental Implants Market: Government Oral Health Initiatives
TABLE 35: U.S. Short Dental Implants Market: Impact of Geopolitical & Supply Chain Tensions
TABLE 36: U.S. Short Dental Implants Market: DSO Vendor Selection Framework
TABLE 37: U.S. Short Dental Implants Market: Clinical Evidence Requirements for Product Adoption
TABLE 38: U.S. Short Dental Implants Market: Implant Length Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by Implant Length
TABLE 40: U.S. Short Dental Implants Market, by Implant Length, 2021–2035 (US$ Billion)
TABLE 41: U.S. Short Dental Implants Market: Segment Share Analysis, by Implant Length, 2025 & 2035 (%)
TABLE 42: U.S. Short Dental Implants Market: 4 mm and Below Extra-Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Short Dental Implants Market: Above 4 mm to 6 mm Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Short Dental Implants Market: Above 6 mm to 8 mm Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Short Dental Implants Market: Clinical Indication Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Clinical Indication
TABLE 47: U.S. Short Dental Implants Market, by Clinical Indication, 2021–2035 (US$ Billion)
TABLE 48: U.S. Short Dental Implants Market: Segment Share Analysis, by Clinical Indication, 2025 & 2035 (%)
TABLE 49: Atrophic Posterior Mandible Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Atrophic Posterior Maxilla Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Single-Tooth Posterior Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Short-Span Bridges & Splinted Restorations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Full-Arch Rehabilitation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Implant-Supported Overdentures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Graft-Avoidance & Sinus-Augmentation Avoidance Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Short Dental Implants Market: Prosthetic Configuration Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by Prosthetic Configuration
TABLE 58: U.S. Short Dental Implants Market, by Prosthetic Configuration, 2021–2035 (US$ Billion)
TABLE 59: U.S. Short Dental Implants Market: Segment Share Analysis, by Prosthetic Configuration, 2025 & 2035 (%)
TABLE 60: Single Crowns Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Splinted Crowns & Fixed Partial Dentures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Implant-Supported Overdentures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Fixed Full-Arch Prostheses Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Screw-Retained versus Cement-Retained Short Implant Restorations Analysis
TABLE 65: U.S. Short Dental Implants Market: Material & Surface Technology Snapshot, 2025
TABLE 66: Segment Dashboard; Definition and Scope, by Material & Surface Technology
TABLE 67: U.S. Short Dental Implants Market, by Material & Surface Technology, 2021–2035 (US$ Billion)
TABLE 68: U.S. Short Dental Implants Market: Segment Share Analysis, by Material & Surface Technology, 2025 & 2035 (%)
TABLE 69: Commercially Pure Titanium Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Titanium Alloy Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Titanium-Zirconium & High-Strength Alloy Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Zirconia Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Advanced Surface-Treated Short Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Short Dental Implants Market: End User Snapshot, 2025
TABLE 75: Segment Dashboard; Definition and Scope, by End User
TABLE 76: U.S. Short Dental Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 77: U.S. Short Dental Implants Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 78: Oral Surgery Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Periodontal Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Prosthodontic & Advanced Restorative Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: General Dental & Implant-Focused Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Dental Support Organizations & Group Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Academic, Hospital-Based & Veteran-Focused Dental Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Short Dental Implants Market: Regional Snapshot, 2025
TABLE 85: Segment Dashboard; Definition and Scope, by Region
TABLE 86: U.S. Short Dental Implants Market, by Region, 2021–2035 (US$ Billion)
TABLE 87: U.S. Short Dental Implants Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 88: U.S. Short Dental Implants Market: Regional Dental Implant Demand & Provider Infrastructure Analysis
TABLE 89: West Region U.S. Short Dental Implants Market: Regional Overview and Trends
TABLE 90: West Region U.S. Short Dental Implants Market: Key Manufacturers & Distribution Ecosystem
TABLE 91: West Region U.S. Short Dental Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Short Dental Implants Market, by Implant Length, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Short Dental Implants Market, by Clinical Indication, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Short Dental Implants Market, by Prosthetic Configuration, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Short Dental Implants Market, by Material & Surface Technology, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Short Dental Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: California Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Washington Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Arizona Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Colorado Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Oregon Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Utah Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Nevada Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: New Mexico Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Idaho Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Montana Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Wyoming Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Alaska Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Hawaii Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region U.S. Short Dental Implants Market: Regional Overview and Trends
TABLE 111: Northeast Region U.S. Short Dental Implants Market: Key Manufacturers & Distribution Ecosystem
TABLE 112: Northeast Region U.S. Short Dental Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Short Dental Implants Market, by Implant Length, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Short Dental Implants Market, by Clinical Indication, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Short Dental Implants Market, by Prosthetic Configuration, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Short Dental Implants Market, by Material & Surface Technology, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Short Dental Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: New York Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Massachusetts Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: New Jersey Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Pennsylvania Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Connecticut Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Maine Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Vermont Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: New Hampshire Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Rhode Island Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Delaware Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Short Dental Implants Market: Regional Overview and Trends
TABLE 129: South Region U.S. Short Dental Implants Market: Key Manufacturers & Distribution Ecosystem
TABLE 130: South Region U.S. Short Dental Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 131: South Region U.S. Short Dental Implants Market, by Implant Length, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Short Dental Implants Market, by Clinical Indication, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Short Dental Implants Market, by Prosthetic Configuration, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Short Dental Implants Market, by Material & Surface Technology, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Short Dental Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: Texas Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Florida Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Georgia Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: North Carolina Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Tennessee Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: South Carolina Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Alabama Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Mississippi Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Louisiana Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Arkansas Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Kentucky Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Oklahoma Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Virginia Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Maryland Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: West Virginia Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Short Dental Implants Market: Regional Overview and Trends
TABLE 152: Midwest Region U.S. Short Dental Implants Market: Key Manufacturers & Distribution Ecosystem
TABLE 153: Midwest Region U.S. Short Dental Implants Market, by State, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Short Dental Implants Market, by Implant Length, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Short Dental Implants Market, by Clinical Indication, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Short Dental Implants Market, by Prosthetic Configuration, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Short Dental Implants Market, by Material & Surface Technology, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Short Dental Implants Market, by End User, 2021–2035 (US$ Billion)
TABLE 159: Illinois Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Ohio Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Michigan Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Minnesota Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Indiana Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Wisconsin Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Missouri Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Iowa Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: Kansas Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Nebraska Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: North Dakota Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: South Dakota Short Dental Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: U.S. Short Dental Implants Market: Competitive Landscape Snapshot, 2025
TABLE 172: U.S. Short Dental Implants Market: Key Company Market Share Analysis, 2025
TABLE 173: U.S. Short Dental Implants Market: Company Positioning Matrix
TABLE 174: U.S. Short Dental Implants Market: Product Portfolio Benchmarking of Key Players
TABLE 175: U.S. Short Dental Implants Market: Competitive Benchmarking by Shortest Implant Length
TABLE 176: U.S. Short Dental Implants Market: Competitive Benchmarking by Surface Technology
TABLE 177: U.S. Short Dental Implants Market: Digital Workflow Capability Benchmarking
TABLE 178: U.S. Short Dental Implants Market: Strategic Developments, Partnerships, M&A & Product Launches
TABLE 179: Straumann Group: Company Profile
TABLE 180: Nobel Biocare: Company Profile
TABLE 181: Dentsply Sirona: Company Profile
TABLE 182: ZimVie Inc.: Company Profile
TABLE 183: BioHorizons: Company Profile
TABLE 184: Bicon Dental Implants: Company Profile
TABLE 185: Implant Direct: Company Profile
TABLE 186: Neodent: Company Profile
TABLE 187: Anthogyr: Company Profile
TABLE 188: CAMLOG: Company Profile
TABLE 189: Hiossen Implant: Company Profile
TABLE 190: Osstem Implant: Company Profile
TABLE 191: Dentium: Company Profile
TABLE 192: MegaGen Implant: Company Profile
TABLE 193: Keystone Dental: Company Profile
TABLE 194: Southern Implants: Company Profile
TABLE 195: Neoss: Company Profile
TABLE 196: MIS Implants Technologies: Company Profile
TABLE 197: ACE Surgical Supply: Company Profile
TABLE 198: Blue Sky Bio: Company Profile
TABLE 199: Noris Medical: Company Profile
TABLE 200: Cortex Dental Implants Industries: Company Profile
TABLE 201: ADIN Dental Implant Systems: Company Profile
TABLE 202: Thommen Medical: Company Profile
TABLE 203: Ditron Dental USA: Company Profile
TABLE 204: U.S. Short Dental Implants Market: Future Market Scenario Analysis, 2026–2035
TABLE 205: U.S. Short Dental Implants Market: Disruptive Technologies Impact Matrix
TABLE 206: U.S. Short Dental Implants Market: Emerging Clinical & Business Trends
TABLE 207: U.S. Short Dental Implants Market: Graft-Avoidance Adoption Outlook
TABLE 208: U.S. Short Dental Implants Market: General Dentist versus Specialist Adoption Outlook
TABLE 209: U.S. Short Dental Implants Market: DSO Implant Standardization Outlook
TABLE 210: U.S. Short Dental Implants Market: Business Opportunities for Startups & Existing Players
TABLE 211: U.S. Short Dental Implants Market: Investment Prioritization Matrix
TABLE 212: U.S. Short Dental Implants Market: Product White-Space Analysis
TABLE 213: U.S. Short Dental Implants Market: Strategic Recommendations for Implant Manufacturers
TABLE 214: U.S. Short Dental Implants Market: Strategic Recommendations for Oral Surgery & Periodontal Practices
TABLE 215: U.S. Short Dental Implants Market: Strategic Recommendations for General Dental & Implant Practices
TABLE 216: U.S. Short Dental Implants Market: Strategic Recommendations for Dental Support Organizations
TABLE 217: U.S. Short Dental Implants Market: Strategic Recommendations for Investors & Private Equity Firms
TABLE 218: U.S. Short Dental Implants Market: Strategic Recommendations for Distributors & Channel Partners
TABLE 219: U.S. Short Dental Implants Market: Strategic Recommendations for New Entrants & Startups
TABLE 220: U.S. Short Dental Implants Market: U.S. Go-to-Market Strategy Considerations
TABLE 221: U.S. Short Dental Implants Market: Clinical Education & Key Opinion Leader Strategy
TABLE 222: U.S. Short Dental Implants Market: Product Positioning & Portfolio Expansion Guidance
TABLE 223: U.S. Short Dental Implants Market: Premium versus Value-Segment Positioning
TABLE 224: U.S. Short Dental Implants Market: Digital Dentistry Partnership Strategy
TABLE 225: U.S. Short Dental Implants Market: Scope Limitation
TABLE 226: U.S. Short Dental Implants Market: Data Use Limitation
TABLE 227: U.S. Short Dental Implants Market: Market Definition & Product Classification Limitation
TABLE 228: U.S. Short Dental Implants Market: Forecasting Limitation
TABLE 229: U.S. Short Dental Implants Market: Clinical Data Interpretation Limitation
TABLE 230: U.S. Short Dental Implants Market: Legal Disclaimer
TABLE 231: U.S. Short Dental Implants Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Short Dental Implants Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. Short Dental Implants Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Analysis
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. Short Dental Implants Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Short Dental Implants Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Short Dental Implants Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. Short Dental Implants Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Evidence & Long-Term Survival Framework
FIGURE 12: Short Implant versus Bone Augmentation Clinical Workflow Economics
FIGURE 13: Dental Practice & DSO Procurement Decision Framework
FIGURE 14: PESTEL Analysis
FIGURE 15: Porter’s Five Forces Analysis
FIGURE 16: Value Chain Analysis
FIGURE 17: Supply Chain Analysis
FIGURE 18: Digital Dentistry & Guided Implantology Impact
FIGURE 19: FDA Regulatory & Market Access Framework
FIGURE 20: Dental Insurance, Financing & Patient Affordability Framework
FIGURE 21: Implant Length Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Implant Length Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: 4 mm and Below Extra-Short Implants Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 24: Above 4 mm to 6 mm Implants Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 25: Above 6 mm to 8 mm Implants Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 26: Clinical Indication Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Clinical Indication Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 28: Atrophic Posterior Mandible Short Implant Opportunity Analysis
FIGURE 29: Atrophic Posterior Maxilla Short Implant Opportunity Analysis
FIGURE 30: Single-Tooth versus Splinted Posterior Restoration Demand Analysis
FIGURE 31: Graft-Avoidance & Sinus-Augmentation Avoidance Opportunity Map
FIGURE 32: Prosthetic Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Prosthetic Configuration Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 34: Short Implant Prosthetic Configuration & Load Distribution Framework
FIGURE 35: Material & Surface Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 36: Material & Surface Technology Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 37: Advanced Short Implant Surface Technology Adoption Landscape
FIGURE 38: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 39: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: DSO versus Independent Dental Practice Short Implant Adoption Analysis
FIGURE 41: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 42: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: West Region U.S. Short Dental Implants Market Share and Leading Players, 2025
FIGURE 44: West Region Market Share Analysis by State, 2025
FIGURE 45: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: California Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 47: Washington Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 48: Arizona Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 49: Colorado Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 50: Oregon Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 51: Utah Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 52: Nevada Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 53: New Mexico Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 54: Idaho Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 55: Montana Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 56: Wyoming Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 57: Alaska Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 58: Hawaii Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 59: Northeast Region U.S. Short Dental Implants Market Share and Leading Players, 2025
FIGURE 60: Northeast Region Market Share Analysis by State, 2025
FIGURE 61: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New York Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 63: Massachusetts Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 64: New Jersey Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 65: Pennsylvania Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 66: Connecticut Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 67: Maine Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Vermont Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: New Hampshire Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 70: Rhode Island Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 71: Delaware Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 72: South Region U.S. Short Dental Implants Market Share and Leading Players, 2025
FIGURE 73: South Region Market Share Analysis by State, 2025
FIGURE 74: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Texas Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 76: Florida Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Georgia Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: North Carolina Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: Tennessee Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: South Carolina Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 81: Alabama Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 82: Mississippi Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 83: Louisiana Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 84: Arkansas Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 85: Kentucky Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 86: Oklahoma Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Virginia Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: Maryland Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: West Virginia Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: Midwest Region U.S. Short Dental Implants Market Share and Leading Players, 2025
FIGURE 91: Midwest Region Market Share Analysis by State, 2025
FIGURE 92: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Illinois Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 94: Ohio Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 95: Michigan Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 96: Minnesota Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Indiana Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Wisconsin Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: Missouri Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: Iowa Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 101: Kansas Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 102: Nebraska Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 103: North Dakota Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 104: South Dakota Short Dental Implants Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 106: Company Positioning Matrix
FIGURE 107: Key Player Short Dental Implant Portfolio Benchmarking
FIGURE 108: Competitive Benchmarking by Shortest Implant Length & Surface Technology
FIGURE 109: Key Player Digital Workflow Capability Benchmarking
FIGURE 110: Strategic Developments, Partnerships, M&A & Product Launches
FIGURE 111: U.S. Short Dental Implant Innovation Roadmap
FIGURE 112: Extra-Short Implant Adoption Roadmap, 2026–2035
FIGURE 113: Graft-Avoidance & Reduced-Augmentation Opportunity Map
FIGURE 114: Future Market Scenario Analysis, 2026–2035
FIGURE 115: Disruptive Technologies Impact Matrix
FIGURE 116: Emerging Clinical & Business Trends Matrix
FIGURE 117: Investment Prioritization Matrix
FIGURE 118: Strategic Growth Roadmap for U.S. Short Dental Implant Companies
FIGURE 119: U.S. Go-to-Market Strategy Framework
FIGURE 120: Clinical Education & Key Opinion Leader Development Framework
FIGURE 121: Product Positioning & Portfolio Expansion Framework
FIGURE 122: DSO Contracting & Digital Dentistry Partnership Framework
FIGURE 123: Report Scope, Limitations & Disclaimer Framework